Notice 2 Jun 2025 compliance, regulations, transportation, audits, unified carrier registration, financial updates

📅UCR Board Meeting Notice

The Unified Carrier Registration Plan Board will convene for Sunshine Act Meetings to discuss essential regulatory matters, including compliance, sanctions, and financial updates related to carrier registration. The public is invited to participate either in-person or via conference call and Zoom, ensuring transparency in the board's activities and decisions.

Learn More
Notice 2 Jun 2025 compliance, federal regulations, labor market, office of personnel management, annuitants, reemployment

📄Analysis of OPM's Notice on Reemployment of Annuitants

Office of Personnel Management (OPM) offers the general public and other federal agencies the opportunity to comment on the review of an expiring information collection, "Reemployment of Annuitants--5 CFR 837.103."

Learn More
Notice 2 Jun 2025 compliance, environmental regulation, epa, tsca, chemical industry

⚗️EPA Notice on Findings for New Chemicals Under TSCA

The Toxic Substances Control Act (TSCA) requires EPA to publish in the Federal Register a statement of its findings after its review of certain TSCA submissions when EPA makes a finding that a new chemical substance or significant new use is not likely to present an unreasonable risk of injury to health or the environment. Such statements apply to premanufacture notices (PMNs), microbial commercial activity notices (MCANs), and significant new use notices (SNUNs) submitted to EPA under TSCA. This document presents statements of findings made by EPA on such submissions during the period from March 1, 2025 to March 31, 2025.

Learn More
Rule 2 Jun 2025 compliance, reporting and recordkeeping requirements, security measures, harbors, coast guard, waterways, marine safety, navigation (water), safety zone, oil spill, gulf of america, maritime operations

🚤Temporary Safety Zone Established in Gulf of America

The Coast Guard is establishing a temporary safety zone one nautical mile in all directions around well #59 at approximate position 29[deg]04'28.919" N, 089[deg]10'48.720" W, near the Pass A Loutre State Wildlife Management Area. The safety zone is needed to protect persons and critical infrastructure from the potential contamination due to an oil spill in the Gulf of America. Entry of vessels or persons into this zone, or movement of vessels within this zone is prohibited unless specifically authorized by the Captain of the Port or a designated representative.

Learn More
Notice 2 Jun 2025 compliance, international trade, business regulation, trade commission, patent infringement, u.s., hydrodermabrasion

⚖️Limited Exclusion Orders and Cease and Desist Rulings on Hydrodermabrasion Systems

Notice is hereby given that the U.S. International Trade Commission ("Commission") has determined to issue a limited exclusion order ("LEO") barring entry of certain hydrodermabrasion systems and components thereof by or on behalf of respondents Medical Purchasing Resource, LLC, Bio-Infusions USA Inc., MIRAmedtech UG, eMIRAmed USA, LLC, and MIRAmedtech SP. Z.O.O. (collectively, "Defaulting Respondents"); and cease and desist orders ("CDOs") against the Defaulting Respondents. The investigation is terminated.

Learn More
Notice 2 Jun 2025 compliance, information collection, cybersecurity, dhs, transportation security, pipeline operators

🛡️TSA Extends Information Collection for Pipeline Security Compliance

This notice announces that the Transportation Security Administration (TSA) has forwarded the Information Collection Request (ICR), Office of Management and Budget (OMB) control number 1652-0055, abstracted below, to OMB for review and approval of an extension of the currently approved collection under the Paperwork Reduction Act (PRA). The ICR describes the nature of the information collection and its expected burden. Specifically, the collection involves the submission of data concerning pipeline security incidents, and the cybersecurity coordinator(s) and alternate(s) contact information.

Learn More
Notice 2 Jun 2025 compliance, regulation, education, immigration, dhs, fee, ice, nonimmigrants

💼Extension of Form I-901 for Nonimmigrant Fee Remittance

In accordance with the Paperwork Reduction Act (PRA) of 1995, the Department of Homeland Security (DHS), U.S. Immigration and Customs Enforcement (ICE) will submit the following Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and clearance.

Learn More
Notice 2 Jun 2025 compliance, international trade, antidumping, china, manufacturing, tariffs, us department of commerce

⚖️U.S. Preliminary Antidumping Determination on Overhead Door Springs

The U.S. Department of Commerce (Commerce) preliminarily determines that overhead door counterbalance torsion springs (overhead door springs) from the People's Republic of China (China) are being, or are likely to be, sold in the United States at less than fair value (LTFV). The period of investigation (POI) is April 1, 2024, through September 30, 2024. Interested parties are invited to comment on this preliminary determination.

Learn More
Notice 2 Jun 2025 compliance, healthcare, regulation, medicare, hospice, joint commission, accreditation

🏥Approval of Joint Commission for Medicare Hospice Accreditation

This notice announces our decision to approve The Joint Commission for continued recognition as a national accrediting organization for hospices that wish to participate in the Medicare or Medicaid programs.

Learn More
Proposed Rule 2 Jun 2025 compliance, healthcare, regulations, transparency, insurance, prescription drugs

💊Request for Information on Prescription Drug Transparency Disclosure

This document is a request for information (RFI) regarding the prescription drug machine-readable file disclosure requirements in the Transparency in Coverage final rules. The Departments of Labor, Health and Human Services (HHS), and the Treasury (the Departments) are issuing this RFI to gather input regarding implementation of the prescription drug machine-readable file disclosure requirements under the Transparency in Coverage final rules, including what modifications to the disclosure requirements or additional technical implementation guidance might be necessary to better ensure the accurate and timely completion of the prescription drug file.

Learn More